Archives
-
HotStart 2X Green qPCR Master Mix Workflow
2026-08-24
Build cleaner SYBR Green assays for gene-expression studies, siRNA knockdown experiments, and RNA-seq validation with a hot-start workflow designed to limit nonspecific amplification. This practical guide connects TRIB3–SLC7A11/GPX4 biology with reaction setup, assay controls, quantitative standards, and troubleshooting.
-
OLIG2 smRNA for Rapid hiPSC Oligodendrocyte Differentiation
2026-08-23
Xu and colleagues developed a transgene-free strategy that uses synthetic modified OLIG2 messenger RNA to differentiate human induced pluripotent stem cells into oligodendrocyte progenitor cells and mature oligodendrocytes. The optimized OLIG2S147A smRNA protocol generated NG2-positive progenitors at greater than 70% purity within six days and produced cells capable of supporting remyelination in vivo.
-
Ionizing Radiation Alters Neuronal Differentiation
2026-08-22
Eom et al. showed that ionizing radiation does more than reduce neural stem-cell survival: it promotes an altered neuronal differentiation program in C17.2 cells and mouse primary neural stem cells. The study links this phenotype to PI3K-dependent STAT3–mGluR1 and p53 signaling, providing a mechanistic framework for understanding radiation-associated neural dysfunction.
-
GPNMB Model Predicts ESCC Immunotherapy Response
2026-08-22
This study links circulating soluble GPNMB to a CAF-Epi niche, SOX2-dependent tumor signaling, and CD8+ T-cell exhaustion in esophageal squamous cell carcinoma. Its multimodal model combines plasma, spatial, and clinicopathologic information to improve prediction of response to PD-1 blockade.
-
Regorafenib Targets RRM2 in Melanoma
2026-08-21
The 2024 iScience study identifies RRM2 as a mechanistically important downstream mediator of Regorafenib activity in melanoma and links its suppression to ERK/E2F3 signaling, apoptosis, and reduced malignant behavior. Its combination of viability, motility, transcriptomic, rescue, and xenograft experiments provides a useful framework for investigating Regorafenib in melanoma and related cancer biology research.
-
From ERK Biology to Fluorescent Translational Proof
2026-08-20
A thought-leadership guide to using the FITC Goat Anti-Rabbit IgG (H+L) Antibody to convert ERK-linked intestinal barrier biology into reproducible, spatially resolved translational evidence.
-
Gramine Drives Ferroptosis in TNBC via CUL3–MTDH
2026-08-20
A 2026 study identifies a CUL3–MTDH ubiquitination pathway through which gramine suppresses triple-negative breast cancer by promoting ferroptosis. Its combination of target-engagement assays, genetic perturbation, rescue experiments, and xenograft models provides a useful mechanistic framework for evaluating gramine in chemoresistant TNBC.
-
CCK8 Workflow for Ovarian Cancer Research
2026-08-19
Build a practical cck8 workflow for measuring proliferation, viability, and treatment response in ovarian cancer models. This guide connects Cell Counting Kit-8 data with the hnRNPL–PIK3CB findings while emphasizing controls, normalization, and troubleshooting.
-
Superoxide Dismutase Activity Assay: Workflow Guide
2026-08-19
Build a fast, colorimetric SOD workflow around xanthine oxidase-generated superoxide and WST-1 detection. This guide emphasizes matrix controls, dilution strategy, and orthogonal interpretation for oxidative stress assay and cancer research applications.
-
GKT137831: Dual Nox1/Nox4 Inhibitor Workflow
2026-08-18
GKT137831 provides a practical way to probe Nox1/Nox4-driven oxidative signaling in pulmonary vascular, fibrotic, and atherosclerosis models. This workflow also shows how to separate upstream reactive oxygen species control from the plasma-membrane execution events highlighted in recent ferroptosis research.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-08-18
Build more reliable PCR amplification and qPCR reaction workflows from low-abundance, long, or structurally complex RNA. HyperScript™ chemistry combines primer flexibility with a thermally stable, high-affinity reverse transcriptase, making it especially useful when conventional reverse transcription produces weak or biased cDNA.
-
Sodium Ascorbate for Reliable Cell Assays
2026-08-17
Learn how Sodium Ascorbate, a mineral salt of ascorbic acid, can support controlled ROS-based cancer cell experiments. This scenario-driven guide explains solvent handling, assay optimization, interpretation, and vendor selection for research reagent SKU B1834.
-
Apigenin Research Workflows for HDAC and AD Models
2026-08-17
Apigenin connects a well-defined malignant mesothelioma growth-inhibition workflow with emerging neuroprotection assays informed by network medicine. This practical guide covers compound handling, dose and time design, HDAC-linked apoptosis, reactive oxygen species production, DNA damage response measurements, and cross-domain interpretation.
-
Small Micellar Paclitaxel for Brain Glioma Therapy
2026-08-16
A 2025 Pharmaceutics study developed Solutol HS-15 micelles containing paclitaxel and achieved a 13.45 nm particle size, high encapsulation, and substantially greater brain-tumor drug exposure than free paclitaxel. In a C6 in situ glioma mouse model, the formulation improved tumor control while avoiding the major weight, liver, and kidney toxicity signals observed with Taxol.
-
A-1331852: BCL-XL Inhibitor Workflows
2026-08-15
A-1331852 supports mechanism-led apoptosis assays, dependency mapping, and combination studies rather than simple endpoint screening. This guide translates BCL-XL biology and glioblastoma findings into practical workflows for cancer research, with handling, optimization, and troubleshooting guidance.